Plain-English translation of NCT07095998 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new way to measure nerve damage caused by cisplatin, a chemotherapy drug used to treat cancer. Researchers want to understand how cisplatin affects nerves and find early warning signs of nerve damage before patients notice symptoms. The study uses specialized nerve function tests called threshold tracking nerve conduction studies to measure how well nerves are working.
Many cancer patients treated with cisplatin develop nerve damage that causes tingling, burning, or numbness in the hands and feet — and there is no good way to catch this damage early. This study aims to find better tools to detect nerve damage sooner, which could help doctors prevent or reduce this painful side effect.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have visits with nerve exams and specialized tests — some in the clinic and some by phone — over several weeks or months depending on which group you're in. For patients starting cisplatin, you'll have baseline tests before treatment starts, follow-up calls during chemotherapy, and additional nerve tests afterward. For patients who already finished cisplatin, you'll come in for nerve testing and answer questions about your symptoms. All visits involve standard neurological exams and specialized nerve conduction studies.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States